Accelerating the Pace of Drug Abuse Research Using Existing Data (R21 Clinical Trial Optional)
Key Information
Due Date: November 15, 2024
Agency: U.S. Department of Health and Human Services (HHS)
Source: Federal
Funding Category:
Health & Human Services
Funding Amount: $581,371
Funding Type: Grant
Match Required: No
Status: Posted
Contact Info:
grantsinfo@nih.gov
See Section VII. Agency Contacts within the full opportunity announcement for all other inquires.
Overview
The objective is to obtain a deeper understanding of the reasons behind drug use behaviors, which includes the use of alcohol, tobacco, prescription drugs, and other drugs, and related disorders. It also strives to advance knowledge of drug use prevention methods, including prevention of HIV infection, as well as how health services are utilized.
This FOA advocates for the full potential use of public datasets and any other existing community-based or clinical datasets. The goal is to enhance our understanding of the causes, pathways of drug use behaviors, and their effects, namely health complications and mortality. Additionally, it aims to identify risk and resilience in the development of psychopathology and to shape strategies that could improve the establishment, testing, implementation, and provision of high-quality, effective, and efficient services for the prevention and treatment of drug abuse and HIV.
Key Dates
Open Date: February 7, 2023
Application Due Date: November 15, 2024
Estimated Award Date: Not Specified
Additional Details
Eligible Activities
- Research and Development
Eligible Applicants
- State governments
- County governments
- City, village or township governments
- Special district governments
- Independent school districts
- Public and State controlled institutions of higher education
- Private institutions of higher education
- Small businesses